Community-reported Visudyne side effects:
Add Your Side Effect to the Community Database
Help Community - Describe Your Visudyne Side Effect Episode
Have You dealt with a Visudyne side effect? Share your experience
Review Visudyne Safety Reports submitted to FDA
Total Visudyne reports: 140.Visudyne FDA safety alerts: No.
Reported deaths: 3 Reported hospitalizations: 28.
Take Visudyne Side Effects Survey, Discuss Visudyne with others
FDA Reported Visudyne Side Effects: visual acuity reduced, retinal haemorrhage, detachment of retinal pigment epithelium, choroidal neovascularisation, disease progression, maculopathy, vitreous haemorrhage, retinal detachment, chorioretinal atrophy, pain in extremity, macular scar.
Visudyne Usage.
If you have questions about Visudyne, you can ask a Health Expert or Ask Patient Community about Visudyne.
Showing 1-100 of 140 Next >
Visudyne Side Effects Report #5197980-6Physician from UNITED STATES reported VISUDYNE problem on Dec 14, 2006. Female patient, 80 years of age, was diagnosed with choroidal neovascularisation and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: macular scar, visual acuity reduced. VISUDYNE dosage: unknown. Patient recovered.
Visudyne Side Effects Report #5383308-5
VISUDYNE problem was reported by a Physician from JAPAN on June 20, 2007. Male patient, 69 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: choroidal neovascularisation, condition aggravated, polypoidal choroidal vasculopathy, retinal haemorrhage. VISUDYNE dosage: unknown. Patient recovered.
Visudyne Side Effects Report #5387868-X
Physician from JAPAN reported VISUDYNE problem on June 27, 2007. Male patient, 57 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: stress, vomiting. VISUDYNE dosage: 9 MG DAILY IV. Patient was hospitalized. Patient recovered.
Visudyne Side Effects Report #5388009-5
VISUDYNE problem was reported by a Physician from JAPAN on June 27, 2007. Male patient, 90 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: choroidal neovascularisation, retinal detachment, retinal haemorrhage, vitreous haemorrhage. VISUDYNE dosage: unknown. During the same period patient was treated with ALLOPURINOL, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.
Visudyne Side Effects Report #5388559-1
Health Professional from FRANCE reported VISUDYNE problem on June 29, 2007. Male patient, 75 years of age, was diagnosed with choroidal neovascularisation and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: cerebral ischaemia, coma, disease progression, paraesthesia. VISUDYNE dosage: unknown. Patient died.
Visudyne Side Effects Report #5393669-9
VISUDYNE problem was reported by a Physician from UNITED STATES on July 20, 2007. Male patient, 75 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. VISUDYNE dosage: 4.8 ML I.V.. During the same period patient was treated with AVASTIN. Patient was hospitalized. Patient recovered.
Visudyne Side Effects Report #5397733-X
Physician from JAPAN reported VISUDYNE problem on July 06, 2007. Male patient, 54 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: chorioretinopathy, maculopathy, metamorphopsia, retinal pigment epitheliopathy, venous occlusion, visual acuity reduced. VISUDYNE dosage: unknown. Patient recovered.
Visudyne Side Effects Report #5399957-4
VISUDYNE problem was reported by a Physician from UNITED STATES on July 27, 2007. Female patient, 81 years of age, weighting 87.00 lb, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, respiratory failure. VISUDYNE dosage: 4.8 ML I.V.. During the same period patient was treated with AVASTIN. Patient died on 01/04/2007.
Visudyne Side Effects Report #5401828-1
Physician from JAPAN reported VISUDYNE problem on July 11, 2007. Male patient, 78 years of age, was diagnosed with polypoidal choroidal vasculopathy and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy. VISUDYNE dosage: unknown. Patient recovered.
Visudyne Side Effects Report #5401829-3
VISUDYNE problem was reported by a Physician from JAPAN on July 11, 2007. Male patient, 69 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: fibrosis, retinal haemorrhage. VISUDYNE dosage: unknown. Patient recovered.
Visudyne Side Effects Report #5401845-1
Physician from JAPAN reported VISUDYNE problem on July 11, 2007. Male patient, 83 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy. VISUDYNE dosage: unknown. Patient recovered.
Visudyne Side Effects Report #5401846-3
VISUDYNE problem was reported by a Physician from JAPAN on July 11, 2007. Male patient, 78 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: detachment of retinal pigment epithelium. VISUDYNE dosage: unknown. Patient recovered.
Visudyne Side Effects Report #5406724-1
Health Professional from FRANCE reported VISUDYNE problem on July 18, 2007. Male patient, 75 years of age, was diagnosed with choroidal neovascularisation and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: cerebral ischaemia, locked-in syndrome. VISUDYNE dosage: unknown. During the same period patient was treated with ANTIHYPERTENSIVES. Patient recovered.
Visudyne Side Effects Report #5408202-2
VISUDYNE problem was reported by a Physician from JAPAN on July 24, 2007. Male patient, 71 years of age, was diagnosed with polypoidal choroidal vasculopathy and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: retinal detachment, retinal haemorrhage, retinal oedema, visual acuity reduced. VISUDYNE dosage: unknown. During the same period patient was treated with TRIAMCINOLONE ACETONIDE. Patient recovered.
Visudyne Side Effects Report #5408203-4
Physician from JAPAN reported VISUDYNE problem on Aug 06, 2007. Male patient, 78 years of age, was diagnosed with chorioretinopathy and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: detachment of retinal pigment epithelium, retinal detachment, retinal haemorrhage. VISUDYNE dosage: unknown. Patient recovered.
Visudyne Side Effects Report #5408353-2
VISUDYNE problem was reported by a Physician from UNITED STATES on Aug 06, 2007. Female patient, 85 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: gallbladder disorder. VISUDYNE dosage: unknown. During the same period patient was treated with LUCENTIS. Patient was hospitalized. Patient recovered.
Visudyne Side Effects Report #5410329-6
Physician from JAPAN reported VISUDYNE problem on July 24, 2007. Male patient, 78 years of age, was diagnosed with polypoidal choroidal vasculopathy and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy, chorioretinal scar, choroidal neovascularisation, condition aggravated. VISUDYNE dosage: unknown. Patient recovered.
Visudyne Side Effects Report #5410342-9
VISUDYNE problem was reported by a Physician from JAPAN on Apr 25, 2007. Male patient, 70 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. VISUDYNE dosage: unknown. During the same period patient was treated with ALLOPURINOL, BEZATOL. Patient was hospitalized. Patient recovered.
Visudyne Side Effects Report #5410343-0
Physician from JAPAN reported VISUDYNE problem on July 24, 2007. Male patient, 83 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy. VISUDYNE dosage: unknown. Patient recovered.
Visudyne Side Effects Report #5410344-2
VISUDYNE problem was reported by a Pharmacist from JAPAN on July 25, 2007. Male patient, 64 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: arrhythmia. VISUDYNE dosage: unknown. During the same period patient was treated with NORVASC, MEVALOIN, KALLIKREIN, DEPAS. Patient recovered.
Visudyne Side Effects Report #5413415-X
Physician from JAPAN reported VISUDYNE problem on July 26, 2007. Female patient, 75 years of age, weighting 86.00 lb, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, respiratory failure. VISUDYNE dosage: 4.2 MG DAILY IV. During the same period patient was treated with ASPIRIN, MEXITIL, CLARITHROMYCIN, DIGOSIN, LANSOPRAZOLE. Patient died on 07/01/2007.
Visudyne Side Effects Report #5420056-7
VISUDYNE problem was reported by a Physician from JAPAN on July 31, 2007. Male patient, 83 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy, disease progression. VISUDYNE dosage: unknown. Patient recovered.
Visudyne Side Effects Report #5420057-9
Physician from JAPAN reported VISUDYNE problem on July 31, 2007. Male patient, 78 years of age, was diagnosed with polypoidal choroidal vasculopathy and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy, choroidal neovascularisation, disease progression, polypoidal choroidal vasculopathy, scar, visual acuity reduced. VISUDYNE dosage: unknown. Patient recovered.
Visudyne Side Effects Report #5423134-1
VISUDYNE problem was reported by a Physician from JAPAN on Aug 06, 2007. Male patient, 71 years of age, weighting 138.9 lb, was diagnosed with polypoidal choroidal vasculopathy and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: disease progression, retinal detachment, retinal haemorrhage, retinal oedema, visual acuity reduced. VISUDYNE dosage: 5.1 ML DAILY IV. During the same period patient was treated with TRIAMCINOLONE ACETONIDE. Patient recovered.
Visudyne Side Effects Report #5427329-2
Physician from UNITED KINGDOM reported VISUDYNE problem on Aug 09, 2007. Female patient, 25 years of age, was diagnosed with choroidal neovascularisation and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: scar, visual acuity reduced. VISUDYNE dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient recovered.
Visudyne Side Effects Report #5427389-9
VISUDYNE problem was reported by a Health Professional from ITALY on Aug 08, 2007. Female patient, 57 years of age, was diagnosed with maculopathy and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: pemphigoid. VISUDYNE dosage: 5 ML DAILY IV. Patient recovered.
Visudyne Side Effects Report #5447010-3
Physician from UNITED STATES reported VISUDYNE problem on Mar 08, 2006. Male patient, 82 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, dizziness, loss of consciousness, nausea, syncope vasovagal. VISUDYNE dosage: 10 MG DAILY IV. During the same period patient was treated with FLUORESCITE, LOPRESSOR, ASPIRIN, ZESTRIL, PLAVIX, HYDROCHLOROTHIAZIDE, MEVACOR, VITAMINS. Patient was hospitalized. Patient recovered.
Visudyne Side Effects Report #5447011-5
VISUDYNE problem was reported by a Health Professional from UNITED STATES on Apr 04, 2006. Male patient, 81 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: hypoacusis, pain. VISUDYNE dosage: unknown. Patient recovered.
Visudyne Side Effects Report #5447012-7
Health Professional from UNITED STATES reported VISUDYNE problem on Apr 07, 2006. Male patient, 78 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased. VISUDYNE dosage: unknown. During the same period patient was treated with SIMVASTATIN, DIGOXIN, ATACAND, WARFARIN, GLIPIZIDE. Patient was hospitalized. Patient recovered.
Visudyne Side Effects Report #5447013-9
VISUDYNE problem was reported by a Health Professional from UNITED STATES on Apr 27, 2006. Male patient, 79 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased. VISUDYNE dosage: unknown. During the same period patient was treated with LUPRON, PROCRIT, CASODEX, PRILOSEC, GLIPIZIDE, ACTOS, VYTORIN, ALTACE. Patient recovered.
Visudyne Side Effects Report #5447014-0
Physician from UNITED STATES reported VISUDYNE problem on Dec 14, 2006. Male patient, 77 years of age, was diagnosed with choroidal neovascularisation and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: detachment of retinal pigment epithelium, retinal haemorrhage, visual acuity reduced. VISUDYNE dosage: unknown. Patient recovered.
Visudyne Side Effects Report #5447015-2
VISUDYNE problem was reported by a Physician from UNITED STATES on Mar 03, 2006. Female patient, 90 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: visual acuity reduced. VISUDYNE dosage: 6 MG/M^2 ONCE IV. During the same period patient was treated with KENALOG. Patient recovered.
Visudyne Side Effects Report #5447016-4
Health Professional from UNITED STATES reported VISUDYNE problem on Sept 28, 2006. Female patient, 68 years of age, was diagnosed with choroidal neovascularisation and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: visual acuity reduced. VISUDYNE dosage: 6 MG/M^2 ONCE IV. During the same period patient was treated with KENALOG. Patient recovered.
Visudyne Side Effects Report #5447017-6
VISUDYNE problem was reported by a Health Professional from UNITED STATES on Nov 07, 2006. Female patient, 80 years of age, was diagnosed with choroidal neovascularisation and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: visual acuity reduced. VISUDYNE dosage: 6 MG/M^2 ONCE IV. During the same period patient was treated with KENALOG. Patient recovered.
Visudyne Side Effects Report #5447018-8
Physician from UNITED STATES reported VISUDYNE problem on Feb 20, 2007. Female patient, 80 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: visual acuity reduced. VISUDYNE dosage: 6 MG/M^2 ONCE IV. During the same period patient was treated with KENALOG. Patient recovered.
Visudyne Side Effects Report #5449576-6
VISUDYNE problem was reported by a Physician from JAPAN on Aug 24, 2007. Male patient, 54 years of age, was diagnosed with polypoidal choroidal vasculopathy and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy, disease progression, maculopathy, metamorphopsia, scotoma, visual acuity reduced. VISUDYNE dosage: unknown. Patient recovered.
Visudyne Side Effects Report #5451948-0
Health Professional from JAPAN reported VISUDYNE problem on Aug 29, 2007. Male patient, 76 years of age, was diagnosed with choroidal neovascularisation and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: choroidal neovascularisation, retinal vascular disorder. VISUDYNE dosage: unknown. Patient recovered.
Visudyne Side Effects Report #5458171-4
VISUDYNE problem was reported by a Physician from GERMANY on Aug 30, 2007. Female patient, 82 years of age, was diagnosed with choroidal neovascularisation and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: disease progression, fluid retention, metamorphopsia, retinal disorder, subretinal fibrosis. VISUDYNE dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient recovered.
Visudyne Side Effects Report #5458176-3
Health Professional from GERMANY reported VISUDYNE problem on Aug 30, 2007. Male patient, 79 years of age, was diagnosed with choroidal neovascularisation and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: macular oedema, retinal pigment epitheliopathy, visual acuity reduced. VISUDYNE dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient recovered.
Visudyne Side Effects Report #5463830-3
VISUDYNE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 04, 2007. Female patient was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: accidental exposure. VISUDYNE dosage: 15 MG DAILY IV. Patient recovered.
Showing 1-100 of 140 Next >
Drug Information: Verteporfin Injection
URL of this page: http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a607060.html
ver'' te pore' finWhy is this medication prescribed?
Verteporfin injection is used in combination with photodynamic therapy (PDT; treatment with a laser light) to treat abnormal growth of leaky blood vessels in the eye caused by wet age-related macular degeneration (AMD; an ongoing disease of the eye that causes loss of the ability to see straight ahead and may make it more difficult to read, drive, or perform other daily activities), pathologic myopia (a serious form of nearsightedness that worsens with time), or histoplasmosis (a fungal infection) of the eye. Verteporfin is in a class of medications called photosensitizing agents. When verteporfin is activated by light, it closes up the leaking blood vessels.
How should this medicine be used?
Verteporfin injection comes as a solid powder cake to be made into a solution to be injected intravenously (into a vein) by a doctor. Verteporfin is usually infused over 10 minutes. Fifteen minutes after the start of the verteporfin infusion, your doctor will administer a special laser light to your eye. If both of your eyes need treatment, the doctor will administer the laser light to your second eye immediately after the first eye. If you have never used verteporfin before and both your eyes need treatment, the doctor will treat only one eye with the laser light on your first visit. If you do not have any serious problems due to the treatment, the doctor will treat your second eye 1 week later with another verteporfin infusion and laser light treatment.
Your doctor will examine your eyes 3 months after verteporfin and PDT treatment to decide whether you need another treatment.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before receiving verteporfin injection,
- tell your doctor and pharmacist if you are allergic to verteporfin, any other medications, or any of the ingredients in verteporfin injection. Ask your pharmacist for a list of the ingredients.
- tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: anticoagulants ('blood thinners'); antihistamines; aspirin or other pain medications; beta carotene; calcium channel blockers such as amlodipine (Norvasc), diltiazem (Cardizem, Dilacor, Tiazac, others), felodipine (Plendil), isradipine (DynaCirc), nicardipine (Cardene), nifedipine (Adalat, Procardia), nimodipine (Nimotop), nisoldipine (Sular), and verapamil (Calan, Isoptin, Verelan); diuretics ('water pills'); griseofulvin (Fulvicin-U/F, Grifulvin V, Gris-PEG ); medications for diabetes, mental illness, and nausea; polymyxin B; sulfa antibiotics; and tetracycline antibiotics such as demeclocycline (Declomycin), doxycycline (Doryx, Vibramycin), minocycline (Dynacin, Minocin), and tetracycline (Sumycin). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
- tell your doctor if you have porphyria (a condition that causes sensitivity to light). Your doctor will probably tell you not to use verteporfin injection.
- tell your doctor if you are being treated with radiation therapy and if you have or have ever had gallbladder or liver disease or any other medical condition.
- tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while using verteporfin injection, call your doctor.
- if you are having surgery, including dental surgery, within 5 days of a verteporfin infusion, tell the doctor or dentist that you have used verteporfin.
- you should know that verteporfin may cause vision problems. Do not drive a car or operate machinery until you know how this medication affects you.
- you should know that verteporfin will make your skin very sensitive to sunlight (likely to get sunburn). Wear a wristband to remind you to avoid exposure of the skin and eyes to direct sunlight or bright indoor light (e.g. tanning salons, bright halogen lighting, and high power lighting used in operating rooms or dental offices) for 5 days after the verteporfin infusion. If you must go outdoors in the daylight during the first 5 days after verteporfin infusion, protect all parts of your body by wearing protective clothing, including a wide-brimmed hat and gloves, and dark sunglasses. Sunscreen will not protect you from sunlight during this time. Do not avoid light entirely during this time; you should expose your skin to soft indoor light.
- talk to your doctor about testing your vision at home during your treatment. Check your vision in both eyes as directed by your doctor, and call your doctor if there are any changes in your vision.
What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What side effects can this medication cause?
Verteporfin injection may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- pain, redness, swelling, or discoloration at the site of the injection
- back pain during the infusion
- dry eye
- itchy eye
- dry, itchy skin
- constipation
- nausea
- muscle pain or weakness
- decreased sensitivity to touch
- decreased hearing
Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately:
- blurred vision
- decrease or changes in vision
- seeing flashes of light
- black spots in vision
- redness and swelling of the eyelid
- pink eye
- chest pain
- fainting
- sweating
- dizziness
- rash
- shortness of breath
- flushing
- rapid or irregular heartbeat
- headache
- lack of energy
- hives and itching
Verteporfin injection may cause other side effects. Call your doctor if you have any unusual problems while using this medication.
In case of emergency/overdose
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.
What other information should I know?
Keep all appointments with your doctor.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Brand name(s):
|
Ask Our Patient Community about Visudyne |
||
|
|
||
|
|
||